Navigation Links
BELLUS HEALTH reports results for first quarter of fiscal 2008
Date:5/5/2008

se periods and equity transactions are translated at historical rates. Any exchange differences resulting from the translation are included in accumulated other comprehensive income presented in shareholders' equity.

Forward-looking Statements

Certain statements included in this Management's Discussion and Analysis may constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities legislation and regulations, and are subject to important risks, uncertainties and assumptions. This forward-looking information includes amongst others, information with respect to the Company's objectives and the strategies to achieve these objectives, as well as information with respect to the Company's beliefs, plans, expectations, anticipations, estimates and intentions. Forward-looking statements generally can be identified by the use of conditional or forward-looking terminology such as "may", "will", "expect", "intend", "estimate", "anticipate", "plan", "foresee", "believe" or "continue" or the negatives of these terms or variations of them or similar terminology. Refer to the Company's filings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission, , for a discussion of the various factors that may affect the Company's future results. Such risks include but are not limited to: the impact of general economic conditions, general conditions in the pharmaceutical and/or nutraceutical industry, changes in the regulatory environment in the jurisdictions in which the BELLUS Health group does business, stock market volatility, fluctuations in costs, and changes to the competitive environment due to consolidation, that actual results may vary once the final and quality-controlled verification of data and analyses has been completed. The results or events predicted in forward-looking information may differ materially from actual results or events. The C
'/>"/>

SOURCE BELLUS Health Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Air pollution linked to cardiovascular risk indices in healthy young adults
5. More proof needed of safety and quality of electronic personal health records
6. Health care incentive model offers collaborative approach
7. Loneliness is bad for your health
8. Mailman School of Public Health study examines link between racial discrimination and substance use
9. Green Tea May Brew Up Healthier Skin
10. For Health Info, Women Often Turn to the Web
11. Record Number of Americans Lack Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...ire/ -- Susan Knapp Pinnas, a leader of provider,... diversified healthcare,experience, has been name...e,company announced today. , As a member o... be,responsible for advancing AvMed,s overall pro...of strong relationships and service excellence. P...
(Date:1/8/2009)... Lighthouse International and EHE International un...W YORK, Jan. 8 Thousand...e New Year that urges them to take care of their v...nd graciously donated by EHE International, was cr...leader in vision healthcare. It will be on display...
(Date:1/8/2009)...likely to be deadly for women and African-American...enomenon account for only part of the differences ... counterparts, according to results published in t...esults present a stark question for doctors and pa...se upon diagnosis don,t account for all the increa...
(Date:1/8/2009)...sets stage for productive partnership , , BALTI... Recovery Coalition (MARC), a broad-based group to...d the groundwork for improving the Medicare Second...with officials from the Center for Medicare and Me...introduce MARC as an industry resource to CMS and ...
Breaking Medicine News(10 mins):Health News:Susan Knapp Pinnas Named AvMed Health Plans' New Senior Vice President of Network 2Health News:61 Million Americans are at Risk of Vision Loss and Don't Even Know It 2Health News:61 Million Americans are at Risk of Vision Loss and Don't Even Know It 3Health News:Why bladder cancer is deadlier for some 2Health News:Why bladder cancer is deadlier for some 3Health News:Why bladder cancer is deadlier for some 4Health News:MARC Coalition Holds Initial Meeting With CMS; Announces New Members 2
...dra Shekhar today died in the Apollo Hospital of t... cancer of the plasma cell and was admitted in Ma... Shekar, a MA from the Allahabad Universtiy, is su...was born on July 1, 1927. He was a Member of Parl...
...gners Friday criticised three university hospitals...a US tobacco giant for research into smoking. Ph...ch simultaneously in South Korea and Japan, said J...ogy professor at Seoul National University Hospita...
...in Scots are more likely to suffer heart attacks, ...j Bhopal and Colin Fischbacher at the University o...ely to survive this trauma in comparison to their ...As part of the study, the researchers linked infor...
... marble, and a symbol of love continues to enjoy i...World. The tomb of Mumtaj has charmed many throug...ge UNESCO site. The new list of seven wonders fu...n 7.7.07 at Lisbon. The announcement was made at a...
Other Medicine News:
(Date:12/27/2008)...te Boisselier breaks 5-year silence, offers to eas...public , , LAS VEGAS, Dec. 27 /PRNewswire-USNew...Baby Eve, the first cloned child, Dr. Brigitte Boi...d project, said Eve and other babies cloned by her...ith no one invading their families, privacy. , ,...
(Date:12/17/2008)...rgest, Most Complex of Its Kind; 80 Percent of Tra...ND, Dec. 17 A multi-disciplinary t...cently performed the first near-total face transp...r procedure performed within the past two weeks, s...who suffered severe facial trauma -- essentially r...
(Date:12/17/2008)...Dec. 17 Delcath Systems...ntment of Pamela R. Contag, Ph.D., to Delcath,s Bo...e executive with extensive experience working with... (LOGO: http://www.newscom.com/cgi-bin/prnh/200... Cobalt Technologies, Inc. in 2006 and served as C...
(Date:12/16/2008)...tudy finds that colonoscopy is associated with low...n of colorectal cancer on the right side of the co...re-USNewswire/ -- A study released today in the A... is associated with lower death rates from colorec...more often on the right side of the colon versus t...
Breaking Medicine Technology:'We're Ready to Prove It!' 2Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 2Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 3Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 2Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 3ASGE Urges Patients to Seek a Qualified Endoscopist Before Undergoing a Colonoscopy for Colorectal Cancer 2ASGE Urges Patients to Seek a Qualified Endoscopist Before Undergoing a Colonoscopy for Colorectal Cancer 3ASGE Urges Patients to Seek a Qualified Endoscopist Before Undergoing a Colonoscopy for Colorectal Cancer 4ASGE Urges Patients to Seek a Qualified Endoscopist Before Undergoing a Colonoscopy for Colorectal Cancer 5Prozac Reduces Disease Activity in MS Patients 18111 1Prozac Reduces Disease Activity in MS Patients 18111 2Incubators Affect Newborns Heart Rates 18109 1Incubators Affect Newborns Heart Rates 18109 2SXC Health Solutions completes acquisition of NMHC 18107 1SXC Health Solutions completes acquisition of NMHC 18107 2FDA Approves Advair 28R 29 250 50 for Reduction of Exacerbations in Patients With COPD 18105 1FDA Approves Advair 28R 29 250 50 for Reduction of Exacerbations in Patients With COPD 18105 2FDA Approves Advair 28R 29 250 50 for Reduction of Exacerbations in Patients With COPD 18105 3FDA Approves Advair 28R 29 250 50 for Reduction of Exacerbations in Patients With COPD 18105 4
...Functionality in Humans of CTI,s,Programmable, Pul...,ChronoDose, BASEL, Switzerland and TRENTON, N.J.,...Inc. (CTI) announced today the successful,completi...programmable, pulsatile, passive transdermal drug/...tends to publish this,clinical data in leading sci...
...SS WIRE)--May 7, 2007 - NanoViricides,Inc. (Pink ...tudies,against rabies and BSL3 in vitro studies ag...e 23rd Annual Symposium of the Pan,American Societ...,May 2. (Pan American Society for Clinical Virolo... studies against Clade 2 H5N1, a Dec. 2006 isolate...
Other Medicine Technology:Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device,Combination Product - ChronoDose 2Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device,Combination Product - ChronoDose 3NanoViricides Drugs Found To Be Highly Effective Against Most,Recent Strain of the H5N1 Avian Flu Virus 2
Duckbill. 3.5 mm tip. Light curve.
2 mm. Angled 13 degrees, 15 mm from angle to tip. Round handle.
2 mm curved tip. Round handle. Designated most popular model or size.
Large. Double-ended. 3 mm pointed end and 5 mm angled end.
Medicine Products: